1887

Abstract

SUMMARY

A clinical isolate of from a cystic fibrosis patient was examined for its ability to produce extracellular toxic material. The organism was grown to stationary phase in a defined medium and toxic material was isolated by ultrafiltration, ion-exchange chromatography on DEAE-Sephacel and gel-filtration chromatography on Sepharose 4B. It consisted of a surface carbohydrate antigen, lipopolysaccharide and protein, and had an LD50 (when injected intraperitoneally into mice) of 395 ±20 μg. The toxicity appeared to be associated with the lipopolysaccharide portion of the complex, because boiling for 15 min and exposure to proteolytic enzymes had no effect on toxicity. However, saponification destroyed the toxicity of the compound. Studies employing radial immunodiffusion with the sera of mice infected with this organism demonstrated production of the complex at levels approaching those sufficient to produce death. When sublethal amounts of this complex were placed in the lungs of specific-pathogen-free rats, the lung pathology observed after 12, 24, 36 and 48 h was extensive. However, antibody generated in rabbits against this material could protect mice against the complex, as well as against challenge by the homologous organism. These data indicate that extracellular toxic material produced by may be responsible for the lethality and lung tissue destruction normally associated with an active pneumonia caused by this organism.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-26-4-269
1988-08-01
2022-01-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/26/4/medmicro-26-4-269.html?itemId=/content/journal/jmm/10.1099/00222615-26-4-269&mimeType=html&fmt=ahah

References

  1. Anwar H., Brown M. R., Cozens R. M., Lambert P. A. 1983a; Isolation and characterization of the outer and cytoplasmic membranes of Pseudomonas cepacia.. Journal of General Microbiology 129:499–507
    [Google Scholar]
  2. Anwar H., Brown M. R., Lambert P. A. 1983b; Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures.. Journal of General Microbiology 129:2021–2027
    [Google Scholar]
  3. Berry L. J., Peterson J. W., Davis C. P. 1982; Pathogenesis and nonspecific diseases. P 192–200 In Baron S. (ed) Medical Microbiology Addison-Wesley, Menlo Park, CA; USA:
    [Google Scholar]
  4. Blessing J. J., Walker J., Maybury B., Yeager A. S., Lewister N. 1979; Pseudomonas cepacia and maltophilia in the cystic fibrosis patient. American Review of Respiratory Disease 119:262 (abstract)
    [Google Scholar]
  5. Blumenkrantz N., Asboe-Hansen G. 1973; New method for quantitative determination of uronic acids.. Analytical Biochemistry 54:484–489
    [Google Scholar]
  6. Boxerbaum B., Klinger J. D. 1984; Pseudomonas cepacia bacteremia in cystic fibrosis. Pediatric Research 18:269A (abstract no. 1043)
    [Google Scholar]
  7. Burkholder W. H. 1950; Sour skin, a bacterial rot on onion bulbs.. Phytopathology 40:115–117
    [Google Scholar]
  8. Cash H. A., Woods D. E., McCullough B., Johanson W. G., Bass J. A. 1979; A rat model of chronic respiratory infection with Pseudomonas aeruginosa.. American Review of Respiratory Disease 119:453–459
    [Google Scholar]
  9. Corey M., Allison L., Prober C., Levison H. 1984; Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981. Journal of Infectious Diseases 149:283
    [Google Scholar]
  10. Fisher R. A. 1973; The exact treatment of 2x2 tables. In Statistical methods for research workers 14th edn Hafner Publishing Company; New York, USA: pp 96–97
    [Google Scholar]
  11. Goldman D. A., Klinger J. D. 1986; Pseudomonas cepacia: Biology, mechanisms of virulence and epidemiology.. Journal of Pediatrics 108:806–812
    [Google Scholar]
  12. Isles A. 1984; Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.. Journal of Pediatrics 104:206–210
    [Google Scholar]
  13. Loewus F. A. 1952; Improvement in anthrone method for determination of carbohydrates. Analytical Chemistry 24:219
    [Google Scholar]
  14. Lonon M. K., Woods D. E., Straus D. C. 1987; Lipase production by clinical isolates of Pseudomonas cepacia. Abstracts of the Annual Meeting of the American Society for Microbiology; K-135 p 225
    [Google Scholar]
  15. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent.. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
  16. Manniello J. M., Heymann H., Adair F. W. 1979; Isolation of atypical lipopolysaccharides from purified cell walls of Pseudomonas cepacia.. Journal of General Microbiology 112:397–400
    [Google Scholar]
  17. McCarthy M. M., Rourke M. H., Spock A. 1980; Bacteremia in patients with cystic fibrosis.. Clinical Pediatrics 19:746–748
    [Google Scholar]
  18. McKevitt A. I., Retzer M. D., Woods D. E. 1987; Development and use of a serotyping scheme for Pseudomonas cepacia.. Serodiagnosis and Immunotherapy 1:177–184
    [Google Scholar]
  19. McKevitt A. I., Woods D. E. 1984; Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis.. Journal of Clinical Microbiology 19:291–293
    [Google Scholar]
  20. Osborn M. J. 1963; Studies on the gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxyoctonate in the lipopolysaccharide of Salmonella typhimurium.. Proceedings of the National Academy of Science of the USA 50:499–506
    [Google Scholar]
  21. Reed L. J., Muench H. A. 1938; A simple method of estimating fifty percent endpoints.. American Journal of Hygiene 27:493–497
    [Google Scholar]
  22. Rietschel E. T., Gottert H., Luderitz O., Westphal O. 1972; Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides.. European Journal of Biochemistry 28:166–173
    [Google Scholar]
  23. Rosenstein B. J., Hall D. E. 1980; Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.. Johns Hopkins Medical Journal 147:188–189
    [Google Scholar]
  24. Straus D. C. 1987; Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.. Infection and Immunity 55:44–48
    [Google Scholar]
  25. Straus D. C., Atkisson D. L., Gamer C. W. 1985; Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae.. Infection and Immunity 50:787–795
    [Google Scholar]
  26. Tablan O. C. 1985; Pseudomonas cepacia colonization in patients with cystic fibrosis: Risk factors and clinical outcome.. Journal of Pediatrics 107:382–387
    [Google Scholar]
  27. Tablan O. C. 1987; Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest 91:527–532
    [Google Scholar]
  28. Thomassen M. J., Demko C. A., Doershuk C. F., Stern R. C., Klinger J. D. 1986; Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.. American Review of Respiratory Disease 134:669–671
    [Google Scholar]
  29. Thomassen M. J., Demko C. A., Klinger J. D., Stem R. C. 1985; Pseudomonas cepacia colonization among patients with cystic fibrosis; a new opportunist.. American Review of Respiratory Disease 131:791–796
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-26-4-269
Loading
/content/journal/jmm/10.1099/00222615-26-4-269
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error